2002
DOI: 10.1177/004947550203200227
|View full text |Cite
|
Sign up to set email alerts
|

Lichen Planus following Hepatitis B Vaccination in an African Girl

Abstract: Lichen planus is a papulosquamous disorder with distinctive clinical features. Until now the aetiology has been largely unknown, however, several postulations have been proposed. The immunopathogenic basis has been most favoured. We report a case of a 13-year-old girl who presented with Lichen planus after receiving the second dose of hepatitis B virus (HBV) vaccination. This report, similar to earlier reports, appears to support the immunopathogenic basis of Lichen planus.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
7
1

Year Published

2002
2002
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 15 publications
2
7
1
Order By: Relevance
“…A possible explanation for this decrease may be the success obtained by primary care physicians with the use of corticosteroids as first‐line management for pruritic conditions, 23 and hence a decrease in referral. Although previous studies have shown an association with hepatitis B 24 and C 25 infection, studies performed recently in our environment did not show any statistical association between lichen planus and these viruses; 26 however, one patient developed lichen planus after hepatitis B vaccination 27 …”
Section: Discussioncontrasting
confidence: 79%
“…A possible explanation for this decrease may be the success obtained by primary care physicians with the use of corticosteroids as first‐line management for pruritic conditions, 23 and hence a decrease in referral. Although previous studies have shown an association with hepatitis B 24 and C 25 infection, studies performed recently in our environment did not show any statistical association between lichen planus and these viruses; 26 however, one patient developed lichen planus after hepatitis B vaccination 27 …”
Section: Discussioncontrasting
confidence: 79%
“…The mean age of LP patients in the present study was 37.20±13.39 years, that being in accordance with the previously documented adult age range of 30-60 years (24,25). Similarly, the mean age of patients with LP in this study was very close to 37.13±12.8 years as documented by Daramola et al previously in a similar environment (15)(16)(17) and 38.8 years as documented in India by Bhattacharya et al (26). There was no age difference between CLP and HLP patients.…”
Section: Discussionsupporting
confidence: 92%
“…Few Nigerian studies have detailed the epidemiology of LP (13)(14)(15)(16)(17), but none has examined the differences or peculiarities of CLP and HLP. The main aim of this study is to research into any existing demographic, clinical and histologic differences between CLP and HLP and to determine the clinical correlates of both types of LP among patients attending the Dermatology Clinics of two Nigerian Teaching Hospitals located in southeastern and southwestern Nigeria.…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, it is noteworthy to mention that Hepatitis B is currently a routine vaccine inclusive in the immunization schedule for the newborn in Nigeria. Occurrences of LP secondary to the vaccine (Engerix B) have been reported (22), yet from this series no LP was found to be secondary to Hepatitis B vaccine immunization.…”
Section: Discussionmentioning
confidence: 55%